CAR-T
| CRISPR Medicine | This is an overview of articles on CAR-T
Sign-up to weekly Newsletter here.
IND Enabling
Phase I
Phase II
Phase III
IND Enabling
Phase I
Phase II
Phase III
Relapsed or Refractory B-cell Lymphoma and Chronic Lymphocytic Leukemia, (NCT04245722)
Sponsors:
Fate Therapeutics
Sponsors:
Fate Therapeutics
IND Enabling
Phase I
Phase II
Phase III
IND Enabling
Phase I
Phase II
Phase III
IND Enabling
Phase I
Phase II
Phase III
IND Enabling
Phase I
Phase II
Phase III
IND Enabling
Phase I
Phase II
Phase III
Relapsed or Refractory Acute Myeloid Leukemia, AML, (NCT06128044)
Sponsors:
Caribou Biosciences, Inc.
Sponsors:
Caribou Biosciences, Inc.
IND Enabling
Phase I
Phase II
Phase III